Filing Details
- Accession Number:
- 0001209191-19-050360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-20 17:16:06
- Reporting Period:
- 2019-07-25
- Accepted Time:
- 2019-09-20 17:16:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-25 | 60 | $5.87 | 5,764,222 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-26 | 60 | $5.86 | 5,764,282 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-29 | 60 | $5.87 | 5,764,342 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-30 | 60 | $5.83 | 5,764,402 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-31 | 60 | $5.94 | 5,764,462 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-02 | 120 | $6.15 | 5,764,582 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-05 | 60 | $6.17 | 5,764,642 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-07 | 60 | $6.07 | 5,764,702 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-09 | 120 | $6.02 | 5,764,822 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 60 | $5.91 | 5,764,882 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-13 | 60 | $5.78 | 5,764,942 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-14 | 60 | $5.49 | 5,765,002 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-16 | 120 | $5.62 | 5,765,122 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-19 | 60 | $5.51 | 5,765,182 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 60 | $5.43 | 5,765,242 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-21 | 60 | $5.49 | 5,765,302 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-22 | 60 | $5.31 | 5,765,362 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-23 | 60 | $5.38 | 5,765,422 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-27 | 120 | $5.19 | 5,765,542 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-29 | 120 | $5.04 | 5,765,662 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-30 | 60 | $5.14 | 5,765,722 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-04 | 60 | $4.79 | 5,765,782 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-06 | 120 | $4.91 | 5,765,902 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-09 | 60 | $5.19 | 5,765,962 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-10 | 60 | $5.38 | 5,766,022 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-11 | 60 | $5.02 | 5,766,082 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-13 | 120 | $5.18 | 5,766,202 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-16 | 60 | $4.97 | 5,766,262 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-18 | 120 | $4.93 | 5,766,382 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-19 | 60 | $5.21 | 5,766,442 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.